520 related articles for article (PubMed ID: 27768763)
21. [Analysis of CGG repeat instability in germline cells from two male fetuses affected with fragile X syndrome].
Duan R; Luo S; Huang W; Li H; Peng Y; Du Q; Wu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):606-9. PubMed ID: 27577204
[TBL] [Abstract][Full Text] [Related]
22. Fragile X syndrome: the FMR1 CGG repeat distribution among world populations.
Peprah E
Ann Hum Genet; 2012 Mar; 76(2):178-91. PubMed ID: 22188182
[TBL] [Abstract][Full Text] [Related]
23. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.
Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z
Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181
[TBL] [Abstract][Full Text] [Related]
24. Mosaicism for the fragile X syndrome full mutation and deletions within the CGG repeat of the FMR1 gene.
Milà M; Castellví-Bel S; Sánchez A; Lázaro C; Villa M; Estivill X
J Med Genet; 1996 Apr; 33(4):338-40. PubMed ID: 8730293
[TBL] [Abstract][Full Text] [Related]
25. Array-based FMR1 sequencing and deletion analysis in patients with a fragile X syndrome-like phenotype.
Collins SC; Coffee B; Benke PJ; Berry-Kravis E; Gilbert F; Oostra B; Halley D; Zwick ME; Cutler DJ; Warren ST
PLoS One; 2010 Mar; 5(3):e9476. PubMed ID: 20221430
[TBL] [Abstract][Full Text] [Related]
26. Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation.
Lu P; Chen X; Feng Y; Zeng Q; Jiang C; Zhu X; Fan G; Xue Z
Sci China Life Sci; 2016 Nov; 59(11):1093-1105. PubMed ID: 27730449
[TBL] [Abstract][Full Text] [Related]
27. Targeted Reactivation of
Haenfler JM; Skariah G; Rodriguez CM; Monteiro da Rocha A; Parent JM; Smith GD; Todd PK
Front Mol Neurosci; 2018; 11():282. PubMed ID: 30158855
[TBL] [Abstract][Full Text] [Related]
28. Reversion to Normal of
Tabolacci E; Pietrobono R; Maneri G; Remondini L; Nobile V; Della Monica M; Pomponi MG; Genuardi M; Neri G; Chiurazzi P
Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32111011
[TBL] [Abstract][Full Text] [Related]
29. Deletion in the FMR1 gene in a fragile-X male.
Mannermaa A; Pulkkinen L; Kajanoja E; Ryynänen M; Saarikoski S
Am J Med Genet; 1996 Aug; 64(2):293-5. PubMed ID: 8844068
[TBL] [Abstract][Full Text] [Related]
30. Deletion of all CGG repeats plus flanking sequences in FMR1 does not abolish gene expression.
Grønskov K; Hjalgrim H; Bjerager MO; Brøndum-Nielsen K
Am J Hum Genet; 1997 Oct; 61(4):961-7. PubMed ID: 9382110
[TBL] [Abstract][Full Text] [Related]
31. Mosaicism for a full mutation, premutation, and deletion of the CGG repeats results in 22% FMRP and elevated FMR1 mRNA levels in a high-functioning fragile X male.
Han XD; Powell BR; Phalin JL; Chehab FF
Am J Med Genet A; 2006 Jul; 140(13):1463-71. PubMed ID: 16761284
[TBL] [Abstract][Full Text] [Related]
32. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B
J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064
[TBL] [Abstract][Full Text] [Related]
33. Nucleosomal occupancy and CGG repeat expansion: a comparative analysis of triplet repeat region from mouse and human fragile X mental retardation gene 1.
Datta S; Alam MP; Majumdar SS; Mehta AK; Maiti S; Wadhwa N; Brahmachari V
Chromosome Res; 2011 May; 19(4):445-55. PubMed ID: 21499798
[TBL] [Abstract][Full Text] [Related]
34. Finding FMR1 mosaicism in Fragile X syndrome.
Gonçalves TF; dos Santos JM; Gonçalves AP; Tassone F; Mendoza-Morales G; Ribeiro MG; Kahn E; Boy R; Pimentel MM; Santos-Rebouças CB
Expert Rev Mol Diagn; 2016; 16(4):501-7. PubMed ID: 26716517
[TBL] [Abstract][Full Text] [Related]
35. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA.
Coffee B; Keith K; Albizua I; Malone T; Mowrey J; Sherman SL; Warren ST
Am J Hum Genet; 2009 Oct; 85(4):503-14. PubMed ID: 19804849
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.
Brasa S; Mueller A; Jacquemont S; Hahne F; Rozenberg I; Peters T; He Y; McCormack C; Gasparini F; Chibout SD; Grenet O; Moggs J; Gomez-Mancilla B; Terranova R
Clin Epigenetics; 2016; 8():15. PubMed ID: 26855684
[TBL] [Abstract][Full Text] [Related]
37. Epigenetics of fragile X syndrome and fragile X-related disorders.
Kraan CM; Godler DE; Amor DJ
Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
[TBL] [Abstract][Full Text] [Related]
38. Stable DNA methylation boundaries and expanded trinucleotide repeats: role of DNA insertions.
Naumann A; Kraus C; Hoogeveen A; Ramirez CM; Doerfler W
J Mol Biol; 2014 Jul; 426(14):2554-66. PubMed ID: 24816393
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous rescue of a FMR1 repeat expansion and review of deletions in the FMR1 non-coding region.
Erbs E; Fenger-Grøn J; Jacobsen CM; Lildballe DL; Rasmussen M
Eur J Med Genet; 2021 Aug; 64(8):104244. PubMed ID: 34022415
[TBL] [Abstract][Full Text] [Related]
40. Two novel intragenic variants in the FMR1 gene in patients with suspect clinical diagnosis of Fragile X syndrome and no CGG repeat expansion.
Carroll R; Shaw M; Arvio M; Gardner A; Kumar R; Hodgson B; Heron S; McKenzie F; Järvelä I; Gecz J
Eur J Med Genet; 2020 Oct; 63(10):104010. PubMed ID: 32688058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
